Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate

被引:33
作者
Morris, Tim P. [1 ]
Jarvis, Christopher I. [2 ]
Cragg, William [3 ]
Phillips, Patrick P. J. [4 ]
Choodari-Oskooei, Babak [1 ]
Sydes, Matthew R. [1 ]
机构
[1] UCL, MRC, Clin Trials Unit, London, England
[2] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
[3] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England
[4] Univ Calif San Francisco, Ctr TB, San Francisco, CA 94143 USA
来源
BMJ OPEN | 2019年 / 9卷 / 09期
基金
英国医学研究理事会;
关键词
Kaplan-Meier; Survival analysis; Data visualisation; Figures; Clinical trials; Graphs; SURVIVAL-DATA; RADIOTHERAPY;
D O I
10.1136/bmjopen-2019-030215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To examine reactions to the proposed improvements to standard Kaplan-Meier plots, the standard way to present time-to-event data, and to understand which (if any) facilitated better depiction of (1) the state of patients over time, and (2) uncertainty over time in the estimates of survival. Design A survey of stakeholders' opinions on the proposals. Setting A web-based survey, open to international participation, for those with an interest in visualisation of time-to-event data. Participants 1174 people participated in the survey over a 6-week period. Participation was global (although primarily Europe and North America) and represented a wide range of researchers (primarily statisticians and clinicians). Main outcome measures Two outcome measures were of principal importance: (1) participants' opinions of each proposal compared with a 'standard' Kaplan-Meier plot; and (2) participants' overall ranking of the proposals (including the standard). Results Most proposals were more popular than the standard Kaplan-Meier plot. The most popular proposals in the two categories, respectively, were an extended table beneath the plot depicting the numbers at risk, censored and having experienced an event at periodic timepoints, and CIs around each Kaplan-Meier curve. Conclusions This study produced a high response number, reflecting the importance of graphics for time-to-event data. Those producing and publishing Kaplan-Meier plots-both authors and journals-should, as a starting point, consider using the combination of the two favoured proposals.
引用
收藏
页数:7
相关论文
共 11 条
  • [1] [Anonymous], 2019, ONLINE SURVEYS FORME
  • [2] Statistics notes - Survival probabilities (the Kaplan-Meier method)
    Bland, JM
    Altman, DG
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7172) : 1572 - 1572
  • [3] Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
    Dearnaley, David P.
    Jovic, Gordana
    Syndikus, Isabel
    Khoo, Vincent
    Cowan, Richard A.
    Graham, John D.
    Aird, Edwin G.
    Bottomley, David
    Huddart, Robert A.
    Jose, Chakiath C.
    Matthews, John H. L.
    Millar, Jeremy L.
    Murphy, Claire
    Russell, J. Martin
    Scrase, Christopher D.
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    [J]. LANCET ONCOLOGY, 2014, 15 (04) : 464 - 473
  • [4] The role of covariates in estimating treatment effects and risk in long-term clinical trials
    Ford, I
    Norrie, J
    [J]. STATISTICS IN MEDICINE, 2002, 21 (19) : 2899 - 2908
  • [5] Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
    Guyot, Patricia
    Ades, A. E.
    Ouwens, Mario J. N. M.
    Welton, Nicky J.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12
  • [6] Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519)
    Johnson, Peter W. M.
    Sydes, Matthew R.
    Hancock, Barry W.
    Cullen, Michael
    Radford, John A.
    Stenning, Sally P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3352 - 3359
  • [7] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [8] Survival ratio plots with permutation envelopes in survival data problems
    Newell, J
    Kay, JW
    Aitchison, TC
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2006, 36 (05) : 526 - 541
  • [9] Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
    Oza, Amit M.
    Cook, Adrian D.
    Pfisterer, Jacobus
    Embleton, Andrew
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    Kristensen, Gunnar
    Carey, Mark S.
    Beale, Philip
    Cervantes, Andres
    Park-Simon, Tjoung-Won
    Rustin, Gordon
    Joly, Florence
    Mirza, Mansoor R.
    Plante, Marie
    Quinn, Michael
    Poveda, Andres
    Jayson, Gordon C.
    Stark, Dan
    Swart, Ann Marie
    Farrelly, Laura
    Kaplan, Richard
    Parmar, Mahesh K. B.
    Perren, Timothy J.
    [J]. LANCET ONCOLOGY, 2015, 16 (08) : 928 - 936
  • [10] Figures in clinical trial reports: current practice & scope for improvement
    Pocock, Stuart J.
    Travison, Thomas G.
    Wruck, Lisa M.
    [J]. TRIALS, 2007, 8 (1)